CD47 and urinary bladder cancer: The same group recently reported on the use of CD47 tumor targeting SERS nanoparticles using Raman imaging for the detection of bladder cancer and found similar results supporting the use of CD47 as a diagnostic imaging target to potentially guide transurethral surgery [53].